These success, together with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the strategy of targeting ACKR3 as a singular method to modulate the opioid process, which could open up new therapeutic avenues for opioid-relevant disorders. In response to this problem, https://edmundm738kbr3.blogolenta.com/profile